Guest Writer: Ian Johnson, Registered Patent Agent, Plant & Planet Law Firm

 

Introduction

Over the past two decades, cannabis has seen increasing public approval, reflected in legalization of medical and recreational marijuana at the state level and federal legalization of industrial hemp. As cannabis and related industries expand, participants are expected to seek competitive advantages, including patent protection. This report examines trends in United States patent filings and issuances related to cannabis since 2000.

While cannabis legalization has been slowly occurring since the 1990s, a significant development was the legalization of recreational marijuana in Colorado and Washington in 2012. Since then, several other states have followed in opening up recreational markets. Therefore, particular attention is given to activity since 2012, as the existence of recreational markets presumably creates greater competition and greater desire to obtain intellectual property protection. This date also conveniently overlaps with the beginning of implementation of the America Invents Act (AIA), which significantly altered the United States patent system. While changes in patent practice post-AIA are beyond the scope of this report, it is useful to examine behavior year over year from 2012 onward to see if legalization has resulting in increased patent activity.

Summary of Findings

Patent activity related to cannabis has increased significantly over the last decade. Filings of cannabis-related patent applications increased 96% between 2012 and 2019, with filings related to recreational and medical cannabis increasing 257% over the same time. The data show that legalization had a demonstrable effect on cannabis patent activity, and that significant resources are being invested in patent protection in the personal use sector of the cannabis industry. These trends are expected to continue, and industry participants should consider this when making decisions regarding business models and intellectual property protections.

Methodology

Research was performed using the LexisNexis Total Patent One database. Results were limited to United States Patent and Trademark Office (USPTO) publications. The following search terms were used:

  • cannab* – use of the wildcard * returns results for cannabis, cannabinoid, and other variants
  • mari?uana – use of the wildcard ? returns results for marijuana and marihuana
  • tetrahydrocannabinol
  • hemp

The listed terms were searched in the title, abstract, or claims of issued patents and printed publications. Searches were limited by time periods as shown in the detailed results. A complete list of all returned documents was created. Because of the structure of the data, a patent could create multiple documents: an issued patent and one or more published applications. For year-over-year results, these duplicates were not removed. This is not considered significant, as publication of an application and issuance generally occur in different years so double counting is minimal. However, duplicates were removed in calculating the number of filings each year to avoid inflation of filing numbers.

Detailed Findings

Overall Cannabis Patent Trends

Cannabis patent activity has increased notably since 2012. Between 2000 and the end of 2011, the USPTO published 3876 documents concerning cannabis inventions. This number consisted of 2865 published applications and 1011 issued patents. Between 2012 and the end of 2019, the USPTO published 5853 documents, consisting of 3980 published applications and 1873 issued patents. This represents 51% more total documents in 2012-2019 compared with 2000-2011. Publications increased year-over-year since 2012, with a 138% increase between 2012 and 2019.  The charts below demonstrate this trend.

Because patent applications are generally not published until the earlier of issuance or 18 months following filing, publication trends are presumably delayed from filing trends. Therefore, it is useful to examine filing trends since 2012. Because of the 18-month delay prior to publication, data for any filings after July 1, 2018 are incomplete as such applications may not have been published. Therefore, both actual values from 2012 through 2018 and projected values for the years 2018 and 2019 are provided below. Using actual filings from 2017, there has been a 75% increase in filing activity since 2012. Using the projected filings for 2019, there has been a 96% increase in filing activity since 2012. The following charts demonstrate the increase in filing of cannabis-related patents since 2012 based on application filing date information.

The AIA transitioned the United State patent system into a first inventor to file system, which is expected to encourage the early filing of provisional applications to secure priority rights. Provisional applications are not published and therefore do not contribute to the publication or filing data above. However, provisional filing activity can be inferred by looking at the claimed priority dates for published applications and issued patents. While the AIA did not fully take effect until March 2013, data are presented since 2012 for ease of comparison with other metrics in this report. Due to incomplete data for 2018 and 2019 as noted above, both actual and projected values are provided. Using actual priority claims for 2017, there has been a 58% increase in provisional filing activity since 2012. Using projected priority claims for 2019, there has been an 80% increase in provisional filing activity since 2012. The following charts demonstrate filing trends based on claimed priority date of the application.

Hemp as a Distinguishing Factor

Hemp has generally enjoyed more acceptance for its industrial uses than marijuana, despite the fact that both constitute cannabis. Inclusion of hemp is necessary to return all results for cannabis related patents. However, to provide a better picture of post-2012 activity in the recreational market, a separate set of searches was performed omitting “hemp” as a search term. It is presumed that doing so will return patents and applications that are more focused on the recreational or medicinal cannabis market. This is based on the fact that many of the results obtained through searching “hemp” include inventions with industrial applications, such as plant fiber composites or textiles, rather than inventions related to personal use of cannabis. For convenience, such patents are referred to as “recreational.” Because this method of discriminating does not perfectly correlate with the subject of any given patent, the results pertaining to the recreational market represent general trends rather than exact activity. Nonetheless, the trends are worth noting for an evolving industry.

“Recreational” Patent Trends

Between 2000 and the end of 2011, the USPTO published 2115 documents associated with recreational cannabis inventions. This number consisted of 1623 published applications and 492 issued patents. Between 2012 and the end of 2019, the USPTO published 3427 documents associated with recreational cannabis inventions, consisting of 2373 published applications and 1054 issued patents. This represents 62% more total documents in 2012-2019 compared with 2000-2011. Total publications increased year-over-year since 2012, with a 253% increase between 2012 and 2019. Published applications saw an increase of 275% over that period, with issued patents seeing a 209% increase. The charts below demonstrate this trend.

Cannabis Patents Trends legalization of medical and recreational marijuana

These findings correspond to the overall increase in cannabis-related patents and demonstrate that the recreational patent sector is growing at an even greater rate than cannabis patents generally. This supports the theory that recreational markets and expansion of legal personal use of cannabis have resulted in an increase in patent activity in the industry.

Again, publication totals are not necessarily the most accurate reflection of patent behavior by cannabis businesses. Therefore, it is useful to examine filing and provisional trends for recreational patents. These results are subject to the same 18-month delay problems noted above, and therefore actual and projected values are provided. Using actual filing data for 2017, there has been a 181% increase in filing activity since 2012. Using projected filing data for 2019, there has been a 257% increase in recreational filing activity since 2012. Using actual priority claims for 2017, there has been a 196% increase in provisional filing activity since 2012. Using projected priority claims for 2019, there has been a 289% increase in recreational provisional filing activity since 2012. The following charts demonstrate recreational filing trends from 2012 to 2019.

Patents that could be classified as recreational made up approximately 53% of all filings between 2000 and 2011. However, following legalization the percent of patents and applications considered recreational has increased to approximately 77% of filings in 2018. The chart below demonstrates the growth of the recreational sector’s share of cannabis patent activity.

Conclusion

In conclusion, the data provide clear evidence that cannabis patent activity has increased over the last decade. Further, patents associated with the recreational and medicinal sectors of the cannabis industry appear to be increasing at an even greater rate.

Further Developments to Watch

The trends demonstrated in the data suggest that cannabis patent activity will continue to increase in 2020 and beyond. This is further expected due to continued legalization efforts. It remains to be seen whether the federal legalization of industrial hemp and implementation of USDA plans will result in the recreational sector’s share of patent activity decreasing, as activity becomes focused on industrial hemp related patents.

An additional area that merits investigation is the issuance rate of cannabis patents. A rudimentary estimate comparing the number of filings to the number of issued patents for 2012-2019 yields an issue rate of approximately 49.6%. Assuming an average time to issuance of 2.5 years, comparing the total filings from 2012-2017 with the total issued patents from 2012-2019 yields an issue rate of approximately 64%. Comparing the total filings from 2012-2017 with the total issued patents from 2014-2019 yields an issue rate of approximately 52%. The issue rates for recreational patents over the same timeframes are similar. However, given the wide variance in time between filing and issuance, the above rates are only speculative. There has been concern that cannabis patents are issued at a higher rate due to the lack of prior art in the field which examiners can cite against the issuance of a patent. The issuance rates noted above do not seem to lend much support to this concern, as the USPTO claims its overall issuance rate is roughly 68%.

Other concerns have been raised about the strength and usefulness of cannabis patents. It is currently unclear how many issued patents are strong enough to survive challenges of invalidity in either post-grant USPTO proceedings or litigation. Currently, only one major cannabis patent is in litigation.[1] As of this writing, the court appears to be treating the case as any other patent infringement suit.[2] However, industry participants will surely watch the case and its outcome may affect the perceived value of cannabis patents and subsequently alter patent activity.

 

 

About the Author

Ian Johnson is a registered patent agent with Plant & Planet Law Firm He works with clients to obtain patents and other protection for their intellectual property and assists clients in licensing, acquisitions, and sales of valuable business assets. He also draws on his experience as an entrepreneur and his broad background across technology, business, and law to support Plant & Planet Law Firm in providing holistic solutions on matters related to business entity formation, corporate governance, and investor relationships. Ian holds a Bachelor of Science in Engineering with a concentration in acoustics from Purdue University. He anticipates receiving his J.D. from the University of Florida Fredric G. Levin College of Law in May 2020. He can be reached at ijohnson@pnplf.com.

 

Plant & Planet Law Firm was founded with a mission to provide legal services to clients whose research, technologies, products, innovations and businesses make the world a better place. The firm leverages its professionals’ variety of legal and technical backgrounds to provide clients solutions in the areas of intellectual property, business law, international law and commerce, and more. The firm is proud of its involvement in the emerging legal cannabis industry, and is also heavily involved in the agriculture, water, clean energy, life sciences, and medicine industries. Plant & Planet is a trusted home for inventors, entrepreneurs, and companies looking to improve the world. All the firm’s activities are tied to its mission statement: “Our clients make the planet better.”

 

[1] United Cannabis Corp. v. Pure Hemp Collective Inc., No. 1:18-CV-01922 (D. Colorado filed July 30, 2018).

[2] United Cannabis Corp. v. Pure Hemp Collective Inc., No. 18-CV-1922-WJM-NYW, 2019 WL 1651846 (D. Colo. Apr. 17, 2019) (Order Denying Defendant’s Early Motion for Partial Summary Judgment). Discovery in the case is ongoing at the time of this report.

 

Cannabis Patents Trends legalization of medical and recreational marijuana

 

 

DISCLAIMER: This report is for informational purposes only and does not constitute legal advice. No attorney-client relationship is created by this report. Neither the author nor Plant & Planet Law Firm will be liable for any harm arising from actions taken in reliance on any information herein.

LET’S DO THIS, AND DO IT RIGHT

Making the Most of Good Intentions and Energy

We all know there are abuses of power and of legal frameworks in the Cannabis industry.  Many good people want to know what they can do about such abuses.  Since I’m a patent attorney, I usually focus on people’s concerns about abuses within the patent system and how they affect the industry and the “Small Cannabis” community.

Patents can be focused, broad, or overbroad/abusive.  I see people discussing Cannabis patents that, with good intentions and abundant energy, misinterpret relatively focused patents as being overbroad.  These situations get earnest people upset and misdirect their energies and attention away from the real problem patents.  Related to this, I get frequent questions about what someone can do to attack an overbroad patent.  I have plenty to say about that, so hang with me.  I think this will be worth your time.

First, Some Definitions

Focused/narrow patent – covers subject matter that was clearly originated by the patent applicant, doesn’t make any real attempt to go beyond that.

Broad but legitimate patent – covers, at its core, something that was legitimately invented by the applicant.  Also covers some logical outgrowths of the core invention but doesn’t cover what is already in the public domain.

Overbroad patent – covers subject matter that was already in the public domain prior to the patent’s filing date.

Some people will want to debate whether all broad patents are abuses, and will argue that anything beyond a focused patent is worthy of attack.  Some of those people are even law professors.  So if you feel this way you’re in good company.  But that’s not today’s topic, so I’m going to direct this discussion to overbroad patents, how to recognize them, and what to do about them.

I also don’t want to get bogged down in, or have this blog dismissed as, an attack on any particular overbroad patent.  This blog may well give you some tools to do that, but I want to be more general and widely applicable.

It’s All About the Claims

The first thing you need to know, to understand a patent or patent application you’re looking at, is that the claims are where the action is.  If you scroll to the end of the part of the document that contains text, you will see one or more numbered, probably long, “sentences” that are usually written very oddly.  Those are the claims.  A patent claim is a verbal definition of the invention and, if you’re looking at an issued patent, the claims are a verbal description of the patent owner’s right to exclude.

Think of a claim as a word-fence around the invention.  If you’re inside the fenced area (i.e., if your product or method meets each and every feature recited in the claim), you infringe the claim.  You are trespassing on the property of the patent owner.  But if there is even one thing the claim recites that your product or method clearly doesn’t have, then you are outside the fence and you don’t infringe the claim.  You are not trespassing; good job!  To read more about patents as fences, click here.

One other thing about patent fences: if a patent fence encloses something that was previously in the public domain, the fence is in the wrong place and needs to come down.  In other words, if a patent claim “reads on” something that already existed before the inventor’s alleged invention, the claimed invention isn’t new and therefore isn’t valid.  Some patent fences, intentionally or accidentally, reach out to cover things that pre-existed the patent.  They are invalid, and the intentional ones are outright abuses of the system.

Knowing What You’re Looking At

So now you know where to find the claims and what they are.  Next let’s figure out whether you are looking at a published application or an issued patent.  And if it’s an issued patent, let’s determine whether it is a plant patent or a utility patent.  That is a very important difference.

Check the numbers on the first page of the document, near the top.  If the number starts with what looks like a four digit year, followed by some more digits, you are looking at a patent application.  If the number is four or five digits and is preceded by “PP” you are looking at a plant patent.  If the number is either 7 or 8 digits, you’re looking at an issued utility patent.  (This is all in reference to US patents and applications.  The numbering system can vary from country-to-country.)

Now that you know what you’re looking at, let’s discuss whether it is worth getting upset about it.

Patent Application – If you see a number like US 2019012345, you’re looking at a published patent application.  Almost all patent applications are published about 18 months after their earliest filing date or priority date.  Most patent applications contain claims that don’t end up getting allowed.

Think of the claims in a patent application as a letter to Santa.  They are a wish list, or the opening round in a negotiation with the patent examiner.  So if you’re looking at a patent application, just realize that the claims you see are not allowed, and don’t necessarily indicate what is really patentable.  They could all be allowed, but chances are fairly good that the final claims in the issued patent will be narrower than the wish list you see in the claims of the published application.

You might see some claims that would be a terrible encroachment on the public domain if they were ever allowed.  You can follow what happens with examination process on “Public PAIR.”  Click here for a blog post that tells you what you need to know to access Public PAIR and become a true patent geek.  And, in certain circumstances, you may even file a protest during the examination process.  This kind of protest requires evidence of unpatentability in the form of printed publications and/or prior patents.  Meanwhile, your best attack on these claims may not be in the form of published material that predates the application.  But if you do have some prior publications that would be on point, you can read about formally protesting pending claims by clicking here.

Plant Patent – If you see a number like US PP12,345, you’re looking at an issued plant patent.  Go to the last page of text and you’ll see there is only one claim, and the claim reads more or less “A new and distinct Cannabis sativa plant named XYZ as illustrated and described herein.”

Here is the most important thing about plant patents: they ONLY cover identical clones of the claimed plant, and you can only infringe a plant patent by asexually propagating (cloning) the patented plant without permission; or by using, selling, or importing parts of the plant (like the flower) without permission.  Therefore a plant patent is a lot like a copyright on a plant—if you aren’t directly copying it, you’re not infringing.  That also means that a plant patent can’t cover things like seeds, which aren’t exactly identical to the claimed cultivar.  Likewise, a plant patent cannot cover using the plant to breed other varieties.

One other important—and frequently misunderstood—thing about plant patents.  They are required by law to include a description of the plant in as much detail as is reasonably possible.  So you may see, in the body of the application, things about the plant’s chemotype or other descriptive information.  This description DOES NOT mean that the applicant is trying to—or ever could—cover all plants with those features.  That description is only there because the law requires it.  So take a deep breath and save your fierceness for certain utility patents, because a plant patent cannot really be overbroad according to our definition.  It’s not possible for a plant patent to cover someone else’s work–something the breeder didn’t invent.  Since a plant patent can only ever cover what the breeder actually originated—one single genotype—there’s nothing to get upset about.  You will do the most good for the most people by focusing on overbroad utility patents.

Utility Patent – you know how to recognize a utility patent and distinguish it from an early wish list (a published application) or a harmlessly narrow plant patent.  Don’t get stuck on the title or the abstract or even the description in the body of the application.  Those all carry information but they DO NOT tell you what the patent actually covers.  Instead go to Claim 1 and read it.  It might be a bit of a slog, but you’ll figure it out.  As you read it, ask yourself whether the claim describes something that you know from your own experience which:

– was sold, published, or otherwise known to the public;

before the earliest filing date or priority date listed on the first page of the document.

If Claim 1 (usually the broadest claim in the patent) really does describe something that existed and was known to the public before it was “invented” by this patent owner, then the claim was erroneously granted and won’t be valid.  For something to be validly patentable, it must be new.  If something was already known before, it was part of the public domain or the public knowledge and isn’t eligible for patent protection.  To read more about patenting and the public domain, click here.  To read more about the almost-always impossibly broad “chemotype patents,” click here.

You Found a “Bad” Patent, Now What?

So what can you do about an issued patent that you believe covers something that wasn’t new at the time of filing?  You have some options.  You could file an “Inter Partes Review” or an “Ex Parte Reexamination” at the USPTO.  These are limited in their potential because they will both require evidence in the form of prior patents or printed publications.  This is especially challenging in the Cannabis industry, in which most of the prior commercial activity was never published—it was intentionally hidden from the outside world even though well-known inside the community.  So if your evidence that the claimed invention was in the public domain exists in some other form—like witness testimony—then you have some other options that will work better.

Your least expensive and most proactive option is to publicize what you know about the claim’s lack of novelty.  Get on social media and publish blogs and articles to point out your evidence that a particular claim is overbroad because it covers things that aren’t new or original to the patent owner.  Be specific about what you know.  And if you’re worried about the noise you’re making constituting some kind of incriminating admission of prior illegal activity, check with a lawyer.  Chances are good that any such activity has a statute of limitations.  Remember, this blog is NOT legal advice–you really do need a live lawyer to learn and analyze your exact facts.

Making Noise for the Public Good

What is the benefit of this kind of publicity?  Well, it may make the patent owner think twice about ever suing anyone for infringing the overbroad claim.  This is because patent litigation is expensive and if you sue someone for patent infringement, one of their defenses can be that the patent is invalid and never should have been granted.  A defendant will have a full opportunity to bring forth a variety of evidence to demonstrate that the claimed invention wasn’t new.  And if the court agrees with this, it will rule that the claim is invalid.  A final judgement that a claim is invalid means it can never be asserted against anyone, ever again.

So if you make a lot of noise about an overbroad patent and why it is invalid, the patent owner may well decide that it is too risky to sue someone who could turn around and invalidate the patent claims.  If your evidence is clear and credible, it would be pretty foolish for the patent owner to sue anyway.  And one thing about big corporations is that they often have shareholders and board members who will be very upset if money is wasted in litigation where an invalid patent is the only outcome.  So the more noise you make (if it is credible), the more you raise the awareness among investors and board members of how risky it would be to ever sue someone.

Defending Your Community

This is related to another aspect of preventive noise-making.  It shows a cohesiveness in the community—that one person’s evidence can be everyone’s defense.  If you are standing up to a bad patent, others will be more likely to stand with you.  This should especially be the case if someone actually were to be sued for infringing an overbroad patent.  If everyone in the Small Cannabis community were willing to share their evidence of patent invalidity to help the defense of one member of the community, you can be sure that Big Cannabis or Big Ag would become aware of this and would be more hesitant to assert overbroad patents.  To read more about standing up to Big Ag, as a united Small Cannabis community, click here.

The Small Cannabis community is rightfully concerned about the threat of overbroad patents.  But Small Cannabis is not paralyzed by fear—it is instead energized by a righteous kind of anger and willingness to stand its ground.  The more effective the community is in pointing out overbroad patents with real, credible evidence, the less likely Big Cannabis will be to continue to try to enforce these patents or even pursue them in the first place.  At some point, the investors and board members of Big Cannabis will see overbroad patents for what they are: a colossal waste of money and political capital.

So go make some noise, after doing some homework to make sure you’re targeting the real abuses.  Your brothers and sisters in Small Cannabis will stand with you and thank you for your efforts.

*Photo — Propagating Purpose Presents: The Grassroots Roundtable Discussion; August 24, 2019; Ukiah, CA; “The Giant We All Face”

IT’S NICE TO BE NEEDED, IF NOT ALWAYS BELIEVED!

“UPOV PBR” in the US is Only Available for Industrial Hemp

There are a lot of people out there with some background in plant-related IP and some of them have strong opinions about the right way to do things.  I know because I hear from them.  That’s a wonderful thing about the open lines of communication available via social media and other tools—it seems nearly everyone is accessible to nearly everyone else.  I wouldn’t want it any other way, because this helps me understand what still needs to be emphasized and reinforced in blogs like this.

I’m going to borrow from some interactions this past week or so, editing very lightly to make it more generally useful.  Here is a question I was asked very recently: “If you have 20 years of experience with UPOV PBR why suggest to average clients to get an expensive plant patent for a Cannabis variety? Most can neither afford to obtain or defend a Cannabis plant patent unless I am mistaken?”

And here is my answer:

UPOV in the US is Uniquely Unlike the Rest of the World

First, UPOV Plant Breeders’ Rights in the US are only available under the USDA Plant Variety Protection Act (PVPA) and only cover seed-propagated plants.  An amendment to the PVPA permitting the USDA PVP system to also cover asexually propagated plants was passed as part of the 2018 Farm Bill, but the USDA is still working out the administrative rules and procedures for this, so applications to cover asexually-propagated plants are still not being accepted.

The original limitation in the PVPA to cover only seed-propagated plants was a special carve-out from the normal UPOV scope that covers both sexually and asexually propagated plants, and it was done this way in the US because asexually propagated plants have been covered under the Plant Patent Act since the 1930s (this Act established the plant-patent system as a special form of protection outside of the normal utility-patent system).

A Special Exception in UPOV Just for the US

The US is unique in having this divided IP system, and the UPOV Act of 1991 was specifically written to accommodate this, by including Article 35(2).  If you look at footnote 8 of the list of UPOV members, that “reservation” was exercised by the US and never has been by any other UPOV member.  Since the US is the only country with a split system, no other country will ever need to invoke Article 35(2).

OK so IP to cover plants in the US, unlike anywhere else in the world, is really three different systems:

  1. USDA PVP (i.e., UPOV) which is still available only for sexually propagated plants (but that exclusion will go away soon).
  2. USPTO plant patenting, which is only available for asexually propagated plants.
  3. USPTO utility patenting, which is available for both modes of propagation.

Testing for Distinctness, Uniformity, and Stability

Something else that is very important to know about the USDA PVP system is that it requires a seed deposit with the authorized USDA seed depository.  And until very recently, no kind of Cannabis seeds were accepted for deposit.  Very recently the USDA started accepting deposits of seeds for “Industrial Hemp” as defined in the Farm Bill (Cannabis sativa having less than 0.3% THC).  Once the USDA is equipped to work with asexually propagated plants, it will require “witness plants” for DUS examination.  DUS testing is the UPOV approach to determining whether a given cultivar is suitable for protection.  The D stands for Distinctness and asks whether the cultivar can be distinguished from the closest know cultivars including but not necessarily limited to the parents.  The U is for Uniformity and asks whether a group of seeds or a group of clones all grow out to being true-to-type—having the characteristics that define the cultivar.  The S comes from Stability and asks whether multiple generations of seeds or clones consistently show the same characteristics as previous generations.  These tests are done under consistent conditions to try to remove the variability that would come from different cultivation techniques from one test to the next.

USDA will never accept deposits or witness plants for a form of Cannabis that is still federally illegal.  And USDA has not yet worked out exactly how they will do DUS testing for clones of Industrial Hemp or any other clonally propagated variety people may wish to protect under USDA PVP/UPOV.

What this means, and it is part of my answer to your question about why I would suggest that people get a plant patent for their Cannabis cultivars is that UPOV protection in the US (the USDA PVP system) is that quite literally not available for most Cannabis cultivars that people want to protect.  The only kinds of Cannabis cultivars protectable via UPOV in the US are cultivars of seed-propagated industrial hemp.

If You Want to Protect Marijuana, You Can’t Go to the USDA

I have clients who want to protect their higher-THC cultivars and even who want to protect hemp cultivars that they are cloning instead of seed-propagating.  If I tried to push them toward UPOV protection in the US, I would be committing malpractice because that form of protection is absolutely not available, period.

The “deposit problem” that makes USDA PVP impossible for everything except industrial hemp is not a problem for plant patents, because the plant patent system does not require a deposit of any kind.  So, there’s no issue of federal illegality–the USPTO has been issuing Cannabis-related patents since the 1940s and has so far issued three plant patents for Cannabis cultivars, with many, many more that are pending and working their way through the process.

Getting Real About the Cost Comparison

Another part of your question also deserves comment, and that is the part about plant patents being expensive.  In fact, a USDA PVP application, including the seed deposit, costs $5150 in USDA fees alone.  So even before paying ANY attorney fees for this, the USDA fees by themselves cost more than we charge for preparing and filing a plant patent application.

Obviously there are USPTO fees on top of what we charge for our work doing plant patent applications, and there are costs associated with responding to the very common requests from the USPTO examiner to provide more information about the cultivar, but we typically see cost averages for plant patents, start-to-finish, including USPTO fees, between $10k and $12k paid out over the course of the process from examination to issuance.  I’m not meaning to imply that this is a trivial amount, but it’s very comparable to the cost of obtaining a USDA PVP registration (if it were even available).  ($5150 plus attorney fees for preparing the application and moving it through the process to allowance would likely add up to a total of $8-10k, and potentially more depending upon an attorney’s billing rate and whether anything unusual arose during the DUS testing that would require attorney work to resolve.)

The expensive form of US IP protection for plants is a utility patent.  However, it is currently the only option available for seed-propagated non-hemp Cannabis.  I won’t go into a lot of utility patents because this email is already getting long.  I have blogged about all of this at PlantLaw.com.

I Don’t Tell People What to Do, I Listen and then Tell Them About Their Actual Options

One last part of your question I’d like to address is the part about suggesting to average clients that they get a plant patent.  In fact, I don’t.  I listen first to what they want to accomplish with their cultivar, how they propagate it, how they are going to commercialize it, why they believe that they need some protection, etc.  Then we talk about the options and what their choices are.  It’s a matter of giving good legal advice that takes into account a client’s situation.  And in some cases, the advice is that if their security is strong enough, maybe they don’t need any formal kind of IP protection, especially if they are having trouble affording it.  See this recent blog post, and please do read all of it before deciding it’s incorrect or it’s bad advice.

OK, I hope that explains why I don’t recommend UPOV for my Cannabis clients.  I absolutely would outside the US, obviously, and will within the US, as one option, once the USDA PVP system accepts such applications.  However, even then, there are numerous considerations that go into deciding the right way to protect a given cultivar.  I went into this in a recent blog.

Are Self-Taught Cannabis Breeders Unqualified? I Say No

Just one other comment about plant breeders, and we may just need to agree to disagree on this point.  I have worked with PhD plant breeders at universities and with BS- or MS-level plant breeders who work for several of my clients.  While they have training in genetics and inheritance, every one of them that I have worked with has been focused on phenotypes.  They do a cross of parents that have some of the traits they are looking for and then they grow out many, many of the offspring and select the ones with the best phenotypes and keep propagating and selecting until they have something worth protecting.

This is exactly what I see self-taught Cannabis breeders also doing.  While I may understand more about genetics, epigenetics, pleiotropic inheritance, recombination rates, the biochemistry of terpenes and cannabinoids and flavonoids, these breeders know what they are doing, and they get very special results.  Obviously, some (including some clients I’m working with) are looking for a particular chemotypic profile or at least for something that meets certain chemotypic criteria.  They get their certificates of analysis (COAs), which are now readily available since many states require them as part of the legal Cannabis market.  And the breeders I work with definitely know how to read a COA and make decisions based on it.  College and formal training is not without value, but from where I sit, having worked with breeders whose training ranges from self-taught to PhDs in plant breeding, it seems to me that they end up doing and looking for the same kinds of things.  Now, if one were doing marker-assisted breeding as many in Big Ag do, that would be different.  I’m talking about fruit and grass and flower breeders, whose work approach in general terms is very similar to that of Cannabis breeders I know.

Well, that blog kind of wrote itself this week, by being lifted straight out of an email I sent.  I hope it’s helpful.  You can always get in touch for help with these things by going to PlantAndPlanet.com.

 

INTELLECTUAL PROPERTY AND “REAL” PROPERTY HAVE IMPORTANT THINGS IN COMMON

Learning from Cannabis Pros and a Football Pro

I was part of a panel discussion recently in a redwood campground in the hills of Mendocino County, California.  That area has become one of my favorite places — partly because of the beauty of the natural setting, one of the few locations where the truly awesome Giant Redwoods can be found.  Another reason I love that area so much is that it is one of the places that old-school Cannabis people have made their living and continue to do so.  The panel included some industry veterans who have been through many more battles than I will probably ever face.  It was educational and exciting to be on this outdoor stage with them, and I learned some new things.  That was enough to make any day a good day.  But there was one topic we touched on, in this panel discussion, that still stuck with me as I was driving away from that beautiful retreat.

I have several vices, but maybe only one outright addiction: NFL football.  I listen to NFL talk on satellite radio year-round.  It’s something most of my friends and family seem to think is a combination of obsessive and tedious, but I don’t mind being a minority of one among my dear ones when it comes to this addiction.  So why am I confessing my maybe-tedious NFL-radio addiction after leading this blog with the grandeur of the redwoods and weed people?

Read more


By Dale Hunt – The opinions expressed here are the author’s own and do not necessarily reflect those of his professional colleagues or his clients.  Nothing in this post should be construed as legal advice.  Meaningful legal advice can only be provided by taking into consideration specific facts in view of the relevant law.

HOW’S THAT FOR A TITLE? YOU’D BETTER READ ON

Hubbub Is a Word and It Happened This Week

I always get the best blog ideas from questions that come up during the week, and this week was no exception.  A friend of mine whom I haven’t yet met in person (interesting times, these) brought to my attention some controversy on social media about a plant patent and asked me a series of great questions about the patent itself and the hubbub around it.  (I’m surprised my spellcheck didn’t go nuts just now, but apparently hubbub is a word.)

The crux of it was this:  There was a plant patent posted somewhere on social media and certain portions of the description were highlighted.  One portion described that the new cultivar was made from an open cross between two traditional varieties.  Another highlighted portion pointed to some phenotypic features of this new variety that could apply broadly to a huge number of other varieties as well.

When you look at a plant patent, you’ll typically see several pages of detailed botanical description like “Stem morphology.—Rugose — longitudinal ribs with corky lenticels on older portions.”  Or you might see curious botanical terminology like “hirsute peduncle.”  And, after you google “hirsute peduncle” to see if that’s even real (it is) and what it looks like (it’s not as weird as it sounds), you will still be left wondering how it helps protect this particular cultivar or distinguish it from others.

Read more


By Dale Hunt – The opinions expressed here are the author’s own and do not necessarily reflect those of his professional colleagues or his clients.  Nothing in this post should be construed as legal advice.  Meaningful legal advice can only be provided by taking into consideration specific facts in view of the relevant law.